Viridian Therapeutics, Inc.’s Post

Last month we announced the completion of enrollment in the THRIVE clinical study. We want to express our sincere appreciation to the many people involved in this study, without whom this milestone would not have been possible. We look forward to continued collaboration to advance science and the development of potential new treatments for people affected by thyroid eye disease (TED). #ThryoidEyeDisease #Autoimmune #RareDisease #Opthomology #Vision  #Endocrinology #Research #TED #ClinicalStudies

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics